Myeloid Malignancies clinical trials at UCLA

1 in progress, 0 open to eligible people

Magrolimab Combinations in Participants With Myeloid Malignancies
Sorry, in progress, not accepting new patients
The goal of this clinical study is to learn more about the safety and dosing of the study drug, magrolimab (Mag), in combination with anti-leukemia therapies in participants with acute myeloid leukemia (AML).
Los Angeles, California and other locations

Last updated: September 14, 2023